From: Joint modelling of longitudinal lipids and time to coronary heart disease in the Jackson Heart Study
 | Incident coronary heart disease |  | No incident coronary heart disease | |||
---|---|---|---|---|---|---|
Variables | Visit1 | Visit2 | Visit3 | Visit1 | Visit2 | Visit3 |
 | (n=236) | (n=82) | (n=120) | (n=3996) | (n=1929) | (n=2564) |
Men | 99 (42.0%) | 31 (37.8%) | 44 (38.3%) | 1417 (35.5%) | 640 (33.2%) | 883 (34.4%) |
Diabetic | 93 (39.4%) | 32 (39.0%) | 47 (39.2%) | 676 (16.9%) | 447 (23.2%) | 678 (26.4%) |
Hypertension | 196 (83.1%) | 73 (89.0%) | 111 (92.5%) | 2070 (51.8%) | 1314 (68.1%) | 1882 (73.4%) |
Statin | 61 (25.9%) | 40 (48.8%) | 69 (57.5%) | 427 (10.7%) | 547 (28.4%) | 938 (36.6%) |
BMI | 31.22 (6.8) | 31.73 (6.7) | 31.04 (7.1) | 31.78 (7.2) | 32.31 (7.2) | 32.31 (7.3) |
HDL | 50.69 (15.2) | 51.64 (15.1) | 56.93 (17.6) | 52.05 (14.4) | 54.67 (15.1) | 58.38 (15.8) |
TC | 205.89 (43.9) | 198.79 (49.0) | 197.52 (51.3) | 199.33 (39.5) | 197.04 (40.5) | 197.91 (39.2) |
TG | 127.40 (125.3) | 113.12 (96.2) | 106.55 (66.1) | 104.45 (76.8) | 99.23 (89.0) | 96.95 (55.8) |
hsCRP | 0.61 (0.9) | 0.84 (1.8) | 0.51 (0.7) | 0.50 (0.9) | 0.55 (0.7) | 0.56 (0.9) |